Myiris.com The company is engaged in the manufacture of active pharmaceutical ingredients and drug intermediates . Shares of the company declined Rs 1.65, or 0.66%, to trade at Rs 246.80. The total volume of shares traded was 37 at the BSE (10.02 a.m., Thursday).
Myiris.com The company is engaged in the manufacture of active pharmaceutical ingredients and drug intermediates . Shares of the company declined Rs 1.65, or 0.66%, to trade at Rs 246.80. The total volume of shares traded was 37 at the BSE (10.02 a.m., Thursday).
Myiris.com The company is engaged in the manufacture of active pharmaceutical ingredients and drug intermediates . Shares of the company declined Rs 1.65, or 0.66%, to trade at Rs 246.80. The total volume of shares traded was 37 at the BSE (10.02 a.m., Thursday).
Pharmaceutical Technology Magazine This guidance applies to the commercial manufacturing of APIs (drug substances or their intermediates ), finished drug products, combination products, and biological drug products. For the purposes of this guidance, the term “manufacturing” includes ...
Pharmaceutical Technology Magazine This guidance applies to the commercial manufacturing of APIs (drug substances or their intermediates ), finished drug products, combination products, and biological drug products. For the purposes of this guidance, the term “manufacturing” includes ...
Pharmaceutical Technology Magazine This guidance applies to the commercial manufacturing of APIs (drug substances or their intermediates ), finished drug products, combination products, and biological drug products. For the purposes of this guidance, the term “manufacturing” includes ...
